Attend an informative webinar discussing the link between digestive health and pro-/post-biotics using data from first human clinical data on patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Increasingly, pre-clinical and clinical research supports the importance of gut health in a wide variety of physiological systems, ranging from digestive health and immune function support to cardiovascular and mental health. With nearly 80 percent of consumers recognizing the link between digestive health and overall well-being, it is not surprising this category is the largest amongst biotic products.
ADM’s most recent clinical study uses the dual probiotic and postbiotic Bifidobacterium longum ES1 in a population of adults with diarrhea-predominant IBS-D. In this webinar, the speaker will walk through the main findings from this study and the science around digestive health and postbiotics.
By attending this webinar, the attendees will gain insights into the following:
- Latest clinical trial data from a large multi-centre randomized controlled trial
- Explore the use of postbiotics for digestive health
- First human clinical data for a dual pro- and post-biotic
Register for this webinar today to explore invaluable insights from a large multi-center randomized controlled trial and first human clinical data for a novel dual pro- and postbiotic for diarrhea-predominant IBS-D.
Speaker
Richard Day, VP of Medical Affairs, ADM
After working as a medical doctor with a specialty in psychiatry for seven years, Dr. Richard Day joined ADM in 2018. In part due to his experience in hospital psychiatry, he has long been interested in the interplay between physical and mental health, which led him to start working on microbiome-based research in neurology and psychiatry.
In his role for ADM, Dr. Day oversees the design and delivery of clinical research across the company’s global Health & Wellness business, with a specific focus on microbiome solutions. Under Dr. Day’s leadership at ADM, the number of published and ongoing clinical trials has more than doubled, with publications secured in some of the world’s leading scientific journals.
Message PresenterWho Should Attend?
This webinar will appeal to researchers, marketers and business development professionals within the health and wellness space, including those who work for food and beverage or dietary supplement companies.
What You Will Learn
Attendees will learn about:
- The growing consumer need for novel digestive health therapies, including a unique case study on the impact of a select probiotic and postbiotic on the health of individuals suffering from digestive ailments such as IBS-D
- How unique probiotics and postbiotics are changing the digestive health landscape
Xtalks Partner
ADM
ADM unlocks the power of nature to enrich the quality of life. We’re a premier global human and animal nutrition company, delivering solutions today with an eye to the future. We’re blazing new trails in health and well-being as our scientists develop groundbreaking products to support healthier living. We’re a cutting-edge innovator leading the way to a new future of plant-based consumer and industrial solutions to replace petroleum-based products. We’re an unmatched agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. And we’re a leader in sustainability, scaling across entire value chains to help decarbonize our industry and safeguard our planet. From the seed of the idea to the outcome of the solution, we give customers an edge in solving the nutritional and sustainability challenges of today and tomorrow. Learn more at www.adm.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account